Biodelivery Sciences International reported $13.14M in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acelrx Pharmaceuticals ACRX:US $ -8.15M 0.96M
Adamas Pharmaceuticals ADMS:US -5502000 3.51M
Agile Therapeutics AGRX:US $ -15.22M 0.88M
Cti Biopharma CTIC:US $ -23.25M 3.87M
Daiichi Sankyo 4568:JP Y 53261M 7192M
Depomed DEPO:US $ 13.35M 17.87M
Endo International Ordinary Shares ENDP:US $ 320.03M 5.28M
JAZZ PHA JAZZ:US $ 195.95M 118.22M
Johnson & Johnson JNJ:US $ 8192M 2043M
Knight Therapeutics Inc GUD:CN C$ 17.02M 7.66M
Lannett LCI:US $ -4.15M 8.72M
Mannkind MNKD:US $ -7.23M 0.79M
Nektar Therapeutics NKTR:US $ -109.98M 3.32M
Pacira Pharmaceuticals PCRX:US $ 36.49M 3.4M
Pfizer PFE:US $ 10235M 2245M
Redhill Biopharma RDHL:US $ -15.06M 7.53M
Revance Therapeutics RVNC:US $ -67.57M 2.28M
Teva Pharmaceutical TEVA:IT 1.14B 1000K